Erin Brosamer, PA
Medical · Orange, CANPI 1710534359
Payments from drug & device makers
Across 1,096 payments — averaging $21.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$3K
- AbbVie$3K
- Teva Pharmaceuticals USA, Inc.$2K
- Otsuka America Pharmaceutical, Inc.$2K
- Alkermes, Inc.$2K
- Neurocrine Biosciences, Inc.$2K
- plus $9K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 102 | $3,477 |
| AbbVie | 137 | $3,121 |
| Teva Pharmaceuticals USA, Inc. | 122 | $2,399 |
| Otsuka America Pharmaceutical, Inc. | 82 | $1,888 |
| Alkermes, Inc. | 72 | $1,859 |
| Neurocrine Biosciences, Inc. | 56 | $1,779 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 118 | $1,666 |
| Lundbeck LLC | 82 | $1,411 |
| Vanda Pharmaceuticals Inc. | 62 | $1,354 |
| Takeda Pharmaceuticals U.S.A., Inc. | 63 | $844 |
| Corium, LLC | 35 | $772 |
| Axsome Therapeutics, Inc. | 19 | $661 |
| Indivior Inc. | 26 | $565 |
| Sunovion Pharmaceuticals Inc. | 39 | $514 |
| Noven Therapeutics, LLC | 20 | $357 |
| Almatica Pharma LLC | 12 | $240 |
| Biogen | 10 | $217 |
| Braeburn Inc. | 6 | $144 |
| Avanir Pharmaceuticals, Inc. | 7 | $135 |
| E.r. Squibb & Sons, L.L.C. | 5 | $105 |
| Tris Pharma Inc | 6 | $100 |
| Idorsia Pharmaceuticals US Inc | 4 | $84 |
| Ironshore Pharmaceuticals Inc. | 2 | $44 |
| Merck | 3 | $44 |
| Azurity Pharmaceuticals, Inc. | 2 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Noven Pharmaceuticals, Inc. | 1 | $23 |
| Novo Nordisk | 1 | $22 |
How this compares
$23,907 in reported general payments places this provider in the 95th percentile of 2,087 medical providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical in Orange
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- Deirdre MoxleyFullerton$149K
- Tri leGardena$127K
- Linda RankLadera Ranch$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.